EurekAlert! -
28 Sep 2020 06:00
(Hubrecht Institute) Researchers in the group of Jeroen den Hertog at the Hubrecht Institute in the Netherlands, in collaboration with researchers in Leiden, have found that a compound inhibits a group of proteins called BMP receptors. This compound, called cercosporamide, was previously only known to inhibit a different group of proteins. When overactive, BMP receptors can lead to several diseases. Studying compounds that may counteract this overactivity may lead to more treatment options in th...
Share this Article